Trial Profile
Pregnancy, Delivery, And Neonatal Outcomes In Subjects With Ongoing Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs NT 100 (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms Thrive-IVF F-U
- Sponsors Nora Therapeutics
- 11 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Nov 2013 New trial record